From pandemic to endemic: A comparison of first, second, and third waves of COVID-19 for applicability in communicable disease management

Abstract

Background: The COVID-19 pandemic created pressure on healthcare systems worldwide. Hospitals have developed strategies to efficiently address the demand for inpatient beds.
Objective: This paper examines changes in length of stay at a southern academic medical center and documents the intervention efforts aimed at providing high quality care and reduced lengths of stay.
Methods: Data include 3,279 patients receiving inpatient treatment for COVID-19 between March 29, 2020, and October 31, 2021. The study data mirrors the three major waves of COVID-19 pandemic in Alabama as reported in Johns Hopkins’ coronavirus resource center. To account for the chronological change in care processes, we interviewed Hospitalists and categorized the interventions by month, June 2020-February 2021. We examined changes in average length of stay and differences in sociodemographic characteristics among the three waves using ANOVA and chi-square tests. Socio-demographic factors analyzed include age, gender, race/ethnicity, marital status, and insurance.
Results: The average length of stay, ICU admissions, and 30-day readmissions each decreased in the second and third waves compared to the first wave. Statistically significant differences were found for ICU admission, age, and insurance for hospitalized patients among waves.
Conclusions: This study contributes to the COVID-19 literature by providing the chronological evolution of ALOS and interventions during the pandemic by highlighting the case of a southern academic medical center.

Keywords

COVID-19 / Length of stay interventions / Telehealth

CONFLICTS OF INTEREST DISCLOSURE

The authors declare they have no conflicts of interest.

References

[1] WHO. Coronavirus disease 2019 (COVID-19) weekly epidemiological update. 2020.

[2] CDC. Slay the Virus: Centers of Disease Control and Prevention; 2021 [updated May 14, 2021]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covi d-data/covidview/index.html

[3] Grimm CA. Hospital experiences responding to the COVID-19 pandemic: results of a national pulse survey March 23-27, 2020. US Department of Health and Human Services Office of Inspector General. 2020. Available from: https://www.oighhsgov/oei/reports/oei-06-20-00300pdf

[4] Grimm CA. Hospital experiences responding to the COVID-19 pandemic: results of a national pulse survey March 23-27, 2020. US Department of Health and Human Services Office of Inspector General. 2020; 41.

[5] Omer SB, Malani P, del Rio C. The COVID-19 Pandemic in the US: A Clinical Update. JAMA. 2020; 323(18): 1767-8. PMid: 32250388. https://doi.org/10.1001/jama.2020.5788

[6] Lavery AM, Preston LE, Ko JY, et al. Characteristics of hospitalized COVID-19 patients discharged and experiencing same-hospital readmission-United States, March-August 2020. Morbidity and Mortality Weekly Report. 2020; 69(45): 1695. PMid: 33180754. https://doi.org/10.15585/mmwr.mm6945e2

[7] Rees EM, Nightingale ES, Jafari Y, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Medicine. 2020; 18(1): 1-22. PMid: 32878619. https://doi.org/10.1186/s12916-020-01726-3

[8] Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region-case series. New England Journal of Medicine. 2020; 382(21): 2012-22. PMid: 32227758. https://doi.org/10.1056/NEJMoa2004500

[9] Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. MedRxiv. 2020. https://doi.org/10.1101/2020.04.08.20057794

[10] Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of coronavirus disease 2019 ( COVID-19) in Jiangsu Province: a multicenter descriptive study. Clinical Infectious Diseases. 2020; 71(15): 706-12. PMid: 32109279. https://doi.org/10.1093/cid/ciaa199

[11] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395(10229): 1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3

[12] Pritchard M, Dankwa E, Hall M, et al. ISARIC COVID-19 Clinical Data Report: 13 July 2020. MedRxiv. 2020.

[13] Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20): 2052-9. PMid: 32320003. https://doi.org/10.1001/jama.2020.6775

[14] Phillips N. The coronavirus is here to stay-here’s what that means. Nature. 2021; 590(7846): 382-4. PMid: 33594289. https://doi.org/10.1038/d41586-021-00396-2

[15] Garibaldi BT, Wang K, Robinson ML, et al. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19. JAMA Network Open. 2021; 4(3): e213071. PMid: 33760094. https://doi.org/10.1001/jamanetworkopen.2021.3071

[16] Hernandez D, Hinshaw D. As Covid-19 vaccines raise hope, cold reality dawns that illness is likely here to stay. Wall Street Journal. 2021. Available from: https://wwwwsj.com/articles/as-vaccines-raise-hope-cold-reality-dawns-covid-19-is-likely-here-to-stay-11612693803

[17] Fang FC, Benson CA, Del Rio C, et al. Covid-19-lessons learned and questions remaining. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020. PMid: 33104186. https://doi.org/10.1093/cid/ciaa1654

[18] Bajekal N. India’s COVID-19 Crisis Is Spiraling Out of Control. It Didn’t Have to Be This Way. TIME. 2021.

[19] Gunia A. Southeast Asia Kept COVID-19 Under Control For Most of the Pandemic. Now It’s Battling Worrying New Surges. TIME. 2021.

[20] Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239-42. PMid: 32091533. https://doi.org/10.1001/jama.2020.2648

[21] Bao H, Liu K, Wu Z, et al. Tuberculosis outbreaks among students in mainland China: a systematic review and meta-analysis. BMC Infectious Diseases. 2019; 19(1): 1-12. PMid: 31727001. https://doi.org/10.1186/s12879-019-4573-3

[22] Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Impact of nonpharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team. Imperial College COVID-19 Response Team. 2020; 20(10.25561): 77482.

[23] Lapidus N, Zhou X, Carrat F, et al. Biased and unbiased estimation of the average length of stay in intensive care units in the Covid-19 pandemic. Annals of Intensive Care. 2020; 10(1): 1-9. PMid: 33063241. https://doi.org/10.1186/s13613-020-00749-6

[24] Chiam T, Subedi K, Chen D, et al. Hospital length of stay among COVID-19-positive patients. Journal of Clinical and Translational Research. 2021; 7(3): 377.

[25] Grutters L, Majoor K, Mattern E, et al. Home telemonitoring makes early hospital discharge of COVID-19 patients possible. Journal of the American Medical Informatics Association. 2020. PMid: 32667985. https://doi.org/10.1093/jamia/ocaa168

[26] Samadizadeh S, Masoudi M, Rastegar M, et al. COVID-19: Why does disease severity vary among individuals? Respir Med. 2021; 180: 106356. PMid: 33713961. https://doi.org/10.1016/j.rmed.2021.106356

[27] Miller J. COVID-19 and the Most Vulnerable Online:Havard Medicine; 2020 [Available from: https://hms.harvard.edu/news/covid-19-most-vulnerable